Top Story

Hypofractionated radiotherapy may improve glottic cancer survival

Hypofractionated radiotherapy may improve glottic cancer survival
June 27, 2017

Hypofractionated radiotherapy improved survival in patients with early-stage glottic cancer compared with conventionally fractionated radiotherapy, according to a study published in Journal of the National Cancer Institute.

“The study was prompted by controversy about whether using a hypofractionated radiation approach was superior to standard radiation approaches for early-stage glottic cancer,” Zain A. Husain, MD, assistant professor of therapeutic radiology and director of head and neck radiotherapy at Smilow Cancer Hospital, told HemOnc Today. “The National Comprehensive Cancer Network guidelines currently say both standard-fraction and hypofractionated options are accepted; however, previous randomized data did suggest a control benefit to hypofractionated radiation.”

FDA News

FDA releases plan to expedite, promote generic drug development

June 27, 2017
As part of its effort to increase competition in the prescription drug market, the FDA released a list of drugs that are off-patent and off-exclusivity without approved…

Armed with CBO report, AAFP sharply critical of Senate health care bill

June 27, 2017
AAFP has unleashed a new round of criticism in the wake of the Congressional Budget Office releasing an analysis of the Senate health care bill known as the Better Care…
In the Journals Plus

Biomarkers may guide personalized therapy for castration-resistant prostate cancer

June 27, 2017
Assessment of androgen receptor gene status in plasma DNA identified patients with castration-resistant prostate cancer with worse outcomes to standard therapy…
In the Journals

Women lack education on harms, benefits of breast cancer screening

June 27, 2017
Women are more likely to know of the benefits of mammography screening, but are not aware of the potential harms, indicating that they lack balanced information from…
More News Headlines »

Polycythemia Vera: Aligning Real World Practices With Current Best Practices

This activity is supported by an independent educational grant from Incyte Corporation.

Ruben A. Mesa, MD, provides practical insights into treating polycythemia vera in this video series. In addition to…
More »
Meeting News

VIDEO: Immunotherapy agent induces response in prostate cancer

June 20, 2017
More »


The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

This activity is supported by an educational grant from Bristol-Myers Squibb.

The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients…
More »
Current Issues
View the Current Issue
HemOnc Today